Skip to main content

An official website of the United States government

OXFORF NANOPORT TECHNOLOGIES NANOPORE P2 SOLO REAGENTS AND SUPPLIES

Waiver type - Procurement: Nonavailability

Agency: NATIONAL INSTITUTES OF HEALTH (7529) • Product Service Code (PSC) : 6509 | Last Modified: 08/14/2023

Procurement Summary

The following Nanopore P2 Solo Reagents and Supplies are manufactured by Oxford Nanopore Technologies in the United Kingdom. These supplies are required for ongoing experiments and are required to be used with our existing GridION sequencing instrument. The GridION is a unique instrument that is a proprietary device that require the abovementioned reagents and supplies. The required supplies are manufactured and only available from Oxford Nanopore Technologies. There are no substitutes or competitors on the market that meet the requirements. The reagents and supplies listed above are required to complete already initiated and mission critical experiments to fulfill the NIAID mission. The Nanopore P2 Solo Reagents and Supplies are required for use in supporting the research that is taking place in the Bacterial Pathogenesis and Antimicrobial Resistance Unit (BPARU) of the Laboratory of Clinical Immunology & Microbiology (LCIM). BPARU studies the mechanisms by which antimicrobial resistance emerges in the natural context of human infection, Genomic sequencing of historical clinical bacterial isolates in combination with in vitro models of adaptive evolution to characterize evolutionary pathways by which present day resistance to specific antimicrobial drug classes has evolved, the pathogenesis of gram-negative bacterial infections in patients with primary immunodeficiency diseases, Application of population genomics approaches to study in vivo adaptive evolution of bacterial infections in the context of acute and chronic infection, and Biochemical studies of bacterial metabolic adaptations that occur during infection. Missions need for the item(s) are intended to satisfy the need for: Our GridION device will operate only with the proprietary reagents and supplies listed above, for which there is no other manufacture or distributor. The experiments for other device on the market.

Did / Will the solicitation include one of the standard BAA provisions announcing the agency’s intention to provide a price preference for domestic end products and construction material?

Yes

Was a sources sought or Request for Information issued?

Yes

OMB Determination

Consistent with Policy

Product

DRUGS AND BIOLOGICALS, VETERINARY USE

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Date Submitted

08/10/2023

Procurement Instrument Identifier (PIID)

N/A

Solicitation ID

N/A

Procurement Stage

Pre-solicitation

Expected Maximum Duration of the Proposed Waiver

0 - 6 months

Waiver Coverage

Individual Waiver

Funding Agency

NATIONAL INSTITUTES OF HEALTH